Patent · US Active

Methods and compositions for treating luminal inflammatory disease

US8753255B2 · kind B2 · utility

1Cited by
2References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2010
Grant dateJun 17, 2014
Priority date—
Expiry dateJan 4, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions, articles, and methods for treating and imaging vulnerable plaque and other inflamed regions in a patient rely on delivery of a conversion electron emitting source (CEES) to a body location. The CEES may be delivered by coupling to a substance which preferentially binds to vulnerable plaque or other inflammatory marker. Alternatively, the CEES can be delivered on a catheter, scaffold, or other device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.